Live Breaking News & Updates on Analysis Sets

Stay updated with breaking news from Analysis sets. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Different dose regimens of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373) in younger and older adults: A phase 2 randomized placebo-controlled trial

In a phase 2 randomized placebo-controlled trial, Neil Formica and coauthors investigate the immunogenicity and safety of different dose regimens of a SARS-CoV-2 recombinant spike protein vaccine in younger and older adults in USA and Australia. ....

United Kingdom , United States , New Zealand , South Africa , Baylor College Of Medicine , Mark Adams , Terry Klein , Fiona Napier , Paul Griffin , Jason Lickliter , Mark Arya , Cheryl Keech , Amber Leah , Paul Nugent , Susan Thackwray , Novavax Gaithersburg , Ira Berger , Mark Turner , Joshua Kim , Astrazeneca Oxford , Charlotte Lemech , Paul Bradley , Mary Beth Manning , Maheshin Ramasamy , University Of Oxford , International Conference On Harmonisation ,